Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging
- PMID: 17085002
- DOI: 10.1016/j.ejrad.2006.10.002
Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging
Abstract
Objective: To compare the clinical value of diffusion-weighted (DW) and T2-weighted (T2W) imaging in detecting prostate cancer using a 3-Tesla (3T) magnetic resonance (MR) system.
Materials and methods: Thirty-seven patients with suspected prostate cancer underwent T2W and DW imaging at 3T using an 8-channel phased-array coil. These images and apparent diffusion coefficient (ADC) maps were read retrospectively and blindly. The results were compared with histopathologic findings, and receiver operating characteristic (ROC) analysis was used to compare the cancer detection performance of T2W and DW imaging.
Results: The areas under the ROC curves for DW imaging and T2W imaging were 0.89 and 0.82, respectively. The performance of DW imaging in prostate cancer detection was significantly better than that of T2W imaging (P=0.0371).
Conclusion: With a 3T MR system, the performance of DW imaging in detecting prostate cancer was better than that of T2W imaging. DW imaging appears to be a robust and reliable method to examine the whole prostate within an acceptable scan time in clinical settings.
Similar articles
-
Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959. Acta Radiol. 2008. PMID: 19031184
-
Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.Acta Radiol. 2007 Jul;48(6):695-703. doi: 10.1080/02841850701349257. Acta Radiol. 2007. PMID: 17611881 Clinical Trial.
-
Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.J Magn Reson Imaging. 2007 Jan;25(1):146-52. doi: 10.1002/jmri.20793. J Magn Reson Imaging. 2007. PMID: 17139633
-
Update of prostate magnetic resonance imaging at 3 T.J Comput Assist Tomogr. 2008 Mar-Apr;32(2):163-72. doi: 10.1097/RCT.0b013e3180683b99. J Comput Assist Tomogr. 2008. PMID: 18379296 Review.
-
Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.Eur Urol. 2012 Feb;61(2):326-40. doi: 10.1016/j.eururo.2011.09.019. Epub 2011 Sep 28. Eur Urol. 2012. PMID: 22000497 Review.
Cited by
-
Role of diffusion-weighted magnetic resonance imaging in prostate cancer evaluation.Radiol Med. 2012 Dec;117(8):1429-40. doi: 10.1007/s11547-012-0832-8. Epub 2012 May 14. Radiol Med. 2012. PMID: 22580813 English, Italian.
-
Outcomes of Robot-Assisted Laparoscopic Prostatectomy with a Posterior Approach to the Seminal Vesicle in 300 Patients.Int Sch Res Notices. 2014 Nov 24;2014:565737. doi: 10.1155/2014/565737. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27379313 Free PMC article.
-
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243. Epub 2013 Nov 13. BJU Int. 2014. PMID: 24215670 Free PMC article.
-
MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology.Radiol Res Pract. 2011;2011:616852. doi: 10.1155/2011/616852. Epub 2010 Jul 20. Radiol Res Pract. 2011. PMID: 22091382 Free PMC article.
-
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.Radiology. 2010 Apr;255(1):89-99. doi: 10.1148/radiol.09090475. Radiology. 2010. PMID: 20308447 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical